Detection of IgG antibodies to BP180 NC16a and C-terminal domains and LAD-1 in nivolumab-associated bullous pemphigoid

Eur J Dermatol. 2019 Oct 1;29(5):554-555. doi: 10.1684/ejd.2019.3618.

Authors

Yu Matsui¹, Teruhiko Makino¹, Norito Ishii², Takashi Hashimoto³, Tadamichi Shimizu¹

Affiliations

¹ Department of Dermatology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan.
² Department of Dermatology, Kurume University School of Medicine, Kurume, Japan.
³ Department of Dermatology, Kurume University School of Medicine, Kurume, Japan, Department of Dermatology, Osaka City University Graduate School of Medicine, Osaka, Japan.

PMID: 31570332
DOI: 10.1684/ejd.2019.3618

No abstract available

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents, Immunological / adverse effects*
Autoantibodies / blood*
Autoantigens / immunology*
Collagen Type XVII
Humans
Immunoglobulin G / immunology*
Male
Nivolumab / adverse effects*
Non-Fibrillar Collagens / immunology*
Pemphigoid, Bullous / chemically induced*

Substances

Antineoplastic Agents, Immunological
Autoantibodies
Autoantigens
Immunoglobulin G
Non-Fibrillar Collagens
Nivolumab